top of page
  • Writer's pictureSurviving Breast Cancer

The Optimal Duration and Dosage of Immunotherapies



Lately, there has been significant research and discussion among scientists and oncologists regarding the optimal duration and dosage of immunotherapy for cancer patients. Immunotherapy has revolutionized cancer treatment by harnessing the body's immune system to target and attack cancer cells, leading to more durable responses and better outcomes for some patients.


At the recent San Antonio Breast Cancer Symposium (December 2023), two topics that received perhaps the greatest scrutiny and discussion were “When is the optimal time to stop immunotherapy treatment”, and “Overall dose reduction efforts”. 


On Thursday, December 26, 2023 the Wall Street Journal published a terrific piece by Brianna Abbott and Jared S. Hopkins titled “Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?” Their fine reporting states “Immunotherapies unleash the immune system on tumors. They have extended the lives of people with melanoma, lung and bladder cancers. They have also been a boon for drug makers generating global sales of $44 billion in 2022.


But some patients are getting more of the drugs than they need, exposing them to side effects and costs they could avoid without risking their cancer recurring. Preliminary research suggests taking the drugs at a lower dose or for a shorter period could be sufficient, but drugmakers haven’t funded the studies needed to confirm the findings.” Link: https://apple.news/A2RxIbXdoS2acj8zq_WWe0w


While immunotherapy has shown promising results, especially in certain cancer types, including melanoma, lung cancer, breast cancer and some types of lymphomas, the approach to timing and duration of treatment is still evolving. Oncologists are continuously evaluating and refining treatment strategies based on new research findings and patient outcomes to optimize the benefits of immunotherapy for cancer patients.


However, determining the ideal duration or timing to stop or modify immunotherapy remains a topic of exploration and debate. Some key considerations in this area include:


  • Sustained Response: For some patients, continuing immunotherapy beyond the standard duration may sustain the response, preventing cancer recurrence or progression.


  • Long-Term Side Effects: Extended use of immunotherapy can lead to immune-related adverse events, which may affect the patient's quality of life. Balancing treatment efficacy with managing these side effects is crucial.


  • Patient-Specific Factors: Response to immunotherapy can vary significantly among individuals. Factors such as tumor type, stage, genetic makeup, and overall health influence the decision-making process.


  • Combination Therapies: Researchers are exploring combinations of immunotherapy with other treatments (like chemotherapy, targeted therapy, or radiation) to optimize effectiveness while potentially minimizing side effects.


  • Biomarkers and Monitoring: Biomarkers are being studied to identify patients who benefit most from continued immunotherapy and those who might safely discontinue treatment without compromising outcomes. Regular monitoring is crucial to detect any signs of disease recurrence.


  • Clinical Trials: Ongoing clinical trials aim to determine the most effective dosing schedules, treatment durations, and combinations of immunotherapies to maximize benefits and minimize risks.


In conclusion, while immunotherapy has shown promising results, especially in certain cancer types, the approach to timing and duration of treatment is still evolving. Oncologists are continuously evaluating and refining treatment strategies based on new research findings and patient outcomes to optimize the benefits of immunotherapy for cancer patients.


87 views

Recent Posts

See All

Meditation Mondays:

Chakra Chanting with Gloria

Mondays at 10:00 a.m. ET 

RSVP

Thursday Night Thrivers:

All Stages Support Group

Thursdays at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Metastatic Breast Cancer Support Group

First and third Thursdays

of the month at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Inflammatory Breast Cancer Support Group

Second Thursday

of the month at 7:00 p.m. ET

RSVP

Tuesday Night Thrivers

Después de un Diagnóstico:

Grupo de Apoyo en Español

2do y Cuarto Martes de cada mes 

7:00 p.m. ET

RSVP​

Breast Cancer Book Club

The first Sunday of the month

RSVP

Mindfulness for Wellbeing

February 23 1:30 p.m. ET

RSVP

Pilates

February 16, 10:00 a.m. ET

RSVP

Restorative Yoga:

The secret Garden

Monday 19,  6:00 p.m. ET

RSVP

Qi Gong

February 27,  11:30 a.m. ET

RSVP

Art Therapy

March 4 6:00 p.m. ET

RSVP

Forest Bathing

March 5,  6:00 p.m. ET

RSVP

Reflect & Recharge

Expressive Writing

March 11,  6:00 p.m. ET

RSVP

Yoga Stretching for DIEP flap

March,  12,  6:00 p.m. ET

RSVP

Yoga Fitness with Chair Assist

March 12 11:30 a.m. ET

RSVP

Más eventos en español

RSVP

Upcoming Events

1

Surviving Breast Cancer provides breast cancer support, events, and webinars at no cost to you! Whether you are looking to gain more knowledge on a particular topic or meet up with other breast cancer survivors, we have something for everyone. 

2

Our standing appointment on Thursdays is for all stages. We also host specific breakout groups once a month for specific stages and subtypes such as Metastatic breast cancer, and Inflammatory Breast Cancer, etc. 

3

The Book Club meets the first Sunday of every month at 11 am ET. You are welcome to join each month or pick and choose your month based on your availability and the book we are reading. 

4

Through art, writing, and other creative modalities, we hold the power to manage our stress, make sense of our now, and relax into moments of stillness. 

5

Free, monthly, online classes in restorative yoga, yoga for breast cancer, and Zumba. 

6

Después de un Diagnóstico

bottom of page